-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Unveiling a Subcutaneous Therapy for 3L+ DLBCL

Sponsor: Genmab and AbbVie
Program: Product Theaters
Sunday, December 10, 2023: 8:00 AM-9:00 AM
Room 5A (San Diego Convention Center)
Samantha Brodkin, DO, MS, Genmab
No relevant conflicts of interest to declare.
For In-Person Participants Only
See more of: Product Theaters